Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alaunos Therapeutics, Inc. | 236,250 | reported | 04 Mar 2021 | tx 6+404,050−55,817 |
| enGene Holdings Inc. | 195,000 | reported | 30 Jan 2026 | tx 2+295,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | GRANT_AWARD | enGene Holdings Inc. | 195,000 | 0.00 USD | deriv |
| 08 Jul 2025 | GRANT_AWARD | enGene Holdings Inc. | 100,000 | 0.00 USD | deriv |
| 04 Mar 2021 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 31,500 | 0.00 USD | |
| 04 Mar 2021 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 236,250 | 0.00 USD | deriv |
| 08 Jan 2021 | SALE | Alaunos Therapeutics, Inc. | 27,894 | 3.12 USD | |
| 29 Jan 2020 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 53,700 | 0.00 USD | |
| 29 Jan 2020 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 82,600 | 0.00 USD | deriv |
| 02 Jan 2020 | SALE | Alaunos Therapeutics, Inc. | 27,923 | 4.55 USD |